Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results ....
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has informed the stock exchanges that its Board of Directors will meet on Monday, February 9, 2026. The Board will consider and approve the unaudited financial results for the quarter ended December 31, 2025 (Q3 FY26), after review by the Audit Committee. The Board will also evaluate the declaration of an interim dividend, if any, on the equity share capital for FY 2025-26. The trading window for dealing in company securities remains closed from January 1, 2026, until February 11, 2026, in line with insider trading norms.
Investors should watch February 9, 2026 for the Q3 FY26 earnings announcement, which could influence near-term stock price movement. A potential interim dividend declaration would be an additional positive catalyst for shareholders.